IRIS
D'ALESSANDRO, MIRIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.423
NA - Nord America 4.352
AS - Asia 824
AF - Africa 98
SA - Sud America 22
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.740
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.314
IT - Italia 2.208
IE - Irlanda 1.553
GB - Regno Unito 1.113
RU - Federazione Russa 684
SE - Svezia 614
SG - Singapore 348
DE - Germania 337
FR - Francia 299
FI - Finlandia 253
CN - Cina 187
IN - India 87
UA - Ucraina 87
ES - Italia 85
CI - Costa d'Avorio 66
CZ - Repubblica Ceca 62
VN - Vietnam 44
CA - Canada 32
NL - Olanda 31
IR - Iran 28
EG - Egitto 24
HK - Hong Kong 24
PH - Filippine 16
CH - Svizzera 15
AU - Australia 14
BE - Belgio 14
JP - Giappone 14
AT - Austria 8
PL - Polonia 8
PT - Portogallo 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
CL - Cile 6
DK - Danimarca 6
EU - Europa 6
MK - Macedonia 6
PE - Perù 6
PK - Pakistan 6
TR - Turchia 6
AZ - Azerbaigian 5
KR - Corea 5
KZ - Kazakistan 5
LK - Sri Lanka 5
LV - Lettonia 5
BD - Bangladesh 4
EE - Estonia 4
GE - Georgia 4
HU - Ungheria 4
RO - Romania 4
AR - Argentina 3
CO - Colombia 3
IL - Israele 3
JO - Giordania 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AM - Armenia 2
BR - Brasile 2
CY - Cipro 2
EC - Ecuador 2
GR - Grecia 2
ID - Indonesia 2
MA - Marocco 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
QA - Qatar 2
TH - Thailandia 2
CR - Costa Rica 1
DZ - Algeria 1
HR - Croazia 1
JM - Giamaica 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 12.740
Salva come PNG Salva come JPEG
Città #
Dublin 1.522
Southend 1.040
Chandler 620
Fairfield 460
Siena 415
Santa Clara 398
Ashburn 375
Lastra a Signa 363
Singapore 281
Helsinki 219
Wilmington 189
Woodbridge 181
Princeton 179
Houston 167
Seattle 160
Cambridge 146
Florence 143
New York 126
Milan 103
Ann Arbor 100
Munich 86
Shanghai 78
Rome 72
Abidjan 66
Fremont 65
Moscow 59
Málaga 57
San Mateo 54
San Diego 46
Dong Ket 44
Boardman 42
Jacksonville 42
Brno 39
Los Angeles 36
Beijing 34
Washington 32
Dallas 29
London 27
Lappeenranta 22
Chicago 21
Agliana 20
Gavirate 20
Naples 20
Olomouc 20
Livorno 18
Tarazona 17
Nuremberg 16
Tanta 16
Brussels 14
Hong Kong 14
Toronto 14
Hyderabad 13
Padova 13
Zanjan 13
Brescia 12
Aachen 11
Chianciano Terme 11
Dearborn 11
Newark 11
Comun Nuovo 10
Pasig 10
Redwood City 10
Amsterdam 9
Espoo 9
Guangzhou 9
Norwalk 9
Pisa 9
Vienna 9
Bangalore 8
Bergamo 8
Catania 8
Grosseto 8
Paris 8
Prato 8
San Francisco 8
Turin 8
Zurich 8
Bologna 7
Cagliari 7
Carrara 7
Falkenstein 7
Leawood 7
Pune 7
Salerno 7
San Casciano in Val di Pesa 7
Sofia 7
Anagni 6
Bari 6
Columbus 6
Dubai 6
Frankfurt am Main 6
Lima 6
Minneapolis 6
Rubano 6
Treviso 6
Verona 6
Winnipeg 6
Alexandria 5
Baku 5
Catanzaro 5
Totale 8.722
Salva come PNG Salva come JPEG
Nome #
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 201
Genetic mechanisms of critical illness in COVID-19 201
Peripheral biomarkers' panel for severe COVID-19 patients 194
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 191
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 185
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 168
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 165
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 158
NK and NKT-like cells in granulomatous and fibrotic lung diseases 154
Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes 154
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 154
Prognostic bioindicators in severe COVID-19 patients 141
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab 140
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 140
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 134
Pathogen-sugar interactions revealed by universal saturation transfer analysis 133
Mapping the human genetic architecture of COVID-19 130
Serial KL-6 measurements in COVID-19 patients 127
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 125
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 123
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 121
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 120
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 120
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 119
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 119
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 118
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab 117
A first update on mapping the human genetic architecture of COVID-19 115
Serum amyloid A: A potential biomarker of lung disorders 115
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 115
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 114
BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis 114
Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor 111
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 109
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 109
Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy 108
An explainable model of host genetic interactions linked to COVID-19 severity 106
Effects of rituximab therapy on B cell differentiation and depletion 105
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 104
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 103
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 103
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 102
Prognostic role of KL-6 in lymphangioleiomyomatosis patients 101
Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis 100
Proteomic characterization of idiopathic pulmonary fibrosis patients: stable versus acute exacerbation 99
Alveolar nitric oxide as a biomarker of COVID-19 lung sequelae: A pivotal study 99
Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of Interstitial Lung Disease 98
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 98
Cluster analysis for clinical sarcoidosis' phenotyping 98
WES profiling of COVID-19 98
Serum KL-6 levels in Pulmonary Langerhans' Cell Histiocytosis 97
Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker? 97
Cytological analysis of bronchoalveolar lavage fluid in asbestos-exposed workers: BALF features in asbestos exposed workers 97
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases 97
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment 97
Interstitial lung disease associated with psoriatic arthritis: a new disease entity? 96
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 94
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting 94
Inflammatory muscle involvement in systemic vasculitis: A systematic review 94
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study 93
Immunologic responses to antifibrotic treatment in IPF patients 93
Comparative Serum Protein Profiles in IPF Patients Before and After Nintedanib Therapy 92
Right cardiac involvement in lung diseases: a multimodality approach from diagnosis to prognostication 92
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy 89
Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases 89
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 89
Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis 87
Common molecular pathways targeted by nintedanib in cancer and IPF: a bioinformatic study 87
A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad 87
Differential redox proteomic profiles of serum from severe asthma patients after one month of Benralizumab and Mepolizumab treatment 87
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 83
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution 83
Clinical and molecular characterization of COVID-19 hospitalized patients 82
Relapse of microscopic polyangiitis after vaccination against COVID-19: a case report 82
Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review 80
Clinical phenotyping in sarcoidosis management 80
Personalized Approach of Severe Eosinophilic Asthma Patients Treated with Mepolizumab and Benralizumab 79
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study 79
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases 79
Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a new protocol for investigating the mechanisms of idiopathic pulmonary fibrosis 78
Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis 76
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 75
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II 75
Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility 74
Specificity of serum amyloid A as a biomarker of idiopathic pulmonary fibrosis 74
A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist 74
Discordant liver fibrosis predictors in virologically suppressed people living with hiv without hepatitis virus infection 72
Serum Amyloid A in lung transplantation 71
Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy 71
Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis 70
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures 69
The Role of Galectins in Chronic Lung Allograft Dysfunction 69
CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients 67
Serial autoantibody detection in interstitial lung diseases: should they be repeated at follow-up? 67
KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach 67
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 66
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review 64
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 63
Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series 62
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study 59
Totale 10.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020374 0 0 0 0 30 24 37 45 68 56 41 73
2020/20211.997 60 97 98 276 173 215 149 242 207 108 195 177
2021/20222.169 160 237 194 146 106 100 87 109 96 286 231 417
2022/20232.800 181 305 334 279 157 479 308 236 176 138 121 86
2023/20243.278 121 95 325 187 177 689 908 166 50 115 135 310
2024/20252.839 629 300 842 417 651 0 0 0 0 0 0 0
Totale 13.485